MiMedx
-
Biologics
Defendant Fights Back Against MiMedx “Blatant Intimidation” Non-Compete Suit
Ex-MiMedx Employee Caralyn Gargan Files Counterclaims for “Predatory Sales Practices” and “Incentivized Fraud” per Mintz Attorneys MARIETTA, Ga., Aug. 26, 2024 /PRNewswire/…
Read More » -
Financial
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
Exclusive agreement provides MIMEDX with rights to commercialize 510(k) cleared, bovine-derived collagen matrix particulate that is indicated for the management…
Read More » -
Financial
MIMEDX Appoints Doug Rice as Chief Financial Officer
MARIETTA, Ga., July 05, 2023 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that…
Read More » -
Financial
MiMedx Appoints Jack Howarth as Senior Vice President, Investor Relations
MARIETTA, Ga., Dec. 01, 2020 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or the “Company”), an industry leader…
Read More » -
MiMedx Announces Addition of Peter M. Carlson
MARIETTA, Ga., Dec. 16, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced…
Read More » -
MiMedx Announces Securities and Exchange Commission Settlement
MARIETTA, Ga., Nov. 26, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced…
Read More » -
Biologics
MiMedx Announces Resignation of Board Member
MARIETTA, Ga., Sept. 20, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound…
Read More » -
Financial
MiMedx Announces Agreement Regarding 2019 and 2020 Shareholder Meetings
MARIETTA, Ga., Aug. 8, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced…
Read More » -
Financial
MiMedx Secures $75 million Non-Dilutive Debt Financing
MARIETTA, Ga., June 11, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound…
Read More » -
Biologics
MiMedx Files Definitive Proxy Materials and Mails Letter to Shareholders
MARIETTA, Ga., June 3, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company“), an industry leader in advanced wound…
Read More » -
Biologics
MiMedx Announces Conclusion of Audit Committee’s Independent Investigation
MARIETTA, Ga., May 23, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound…
Read More » -
Biologics
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
MARIETTA, Ga., May 9, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound…
Read More » -
Biologics
MiMedx Announces Board Approval of Long-Range Strategic Plan
MARIETTA, Ga., April 11, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care…
Read More » -
Financial
MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq
MARIETTA, Ga., Nov. 7, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today…
Read More » -
Biologics
MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference
MARIETTA, Ga., Nov. 6, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today…
Read More »